Phil is a Biochemical Engineer by profession with 30+ years in a range of capital and revenue related roles across the manufacturing and R&D areas of the Business. More recently he was AstraZeneca’s Global Head of Asset Management before leading on defining AZ’s operational requirements for their new R&D Site in Cambridge UK. 

Phil is a contributor to ISPE’s recently introduced Good Practice Guide on Asset Management and is a great advocate of sharing and growing the understanding of good data management practices in the Biopharma Industry.